Belpointe Asset Management LLC Alnylam Pharmaceuticals, Inc. Transaction History

Belpointe Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$182.66 - $235.53 $365 - $471	-2 Reduced 1.87%	105 $21,000
Q4 2022 Feb 08, 2023	BUY	$185.53 - $241.31 $19,851 - $25,820	107 New	107 $25,000
Q2 2022 Aug 02, 2022	SELL	$120.42 - $169.29 $80,681 - $113,424	-670 Closed	0 $0
Q1 2022 Apr 28, 2022	BUY	$127.18 - $173.91 $85,210 - $116,519	670 New	670 $110,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.